Comment on: "Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia"

Pediatr Blood Cancer. 2023 Oct;70(10):e30532. doi: 10.1002/pbc.30532. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / therapeutic use
  • Child
  • Humans
  • Hydroxyurea* / therapeutic use
  • Medication Adherence

Substances

  • Hydroxyurea
  • Antisickling Agents